Skip to main content
MGRX
NASDAQ Industrial Applications And Services

Mangoceuticals to Merge with Nuclear Startup Nuclea Energy, Leaving Existing Shareholders with Just 4%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Neutral
Importance info
9
Price
$0.54
Mkt Cap
$9.488M
52W Low
$0.162
52W High
$2.75
52W Position info
233% above low
Off High info
80% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

MGRX has more than doubled off its 52-week low of $0.162 on light trading volume (0.2× avg).

Summary

Mangoceuticals is being reverse-merged into nuclear startup Nuclea Energy, leaving existing shareholders with just 4% of the combined company. The deal includes a $15 million PIPE, a CEO exit package, and governance changes to secure approval.


Key Events · M&A and Partnerships · MGRX

  • Reverse Merger with Nuclea Energy

    Mangoceuticals entered into a Business Combination Agreement with Nuclea Energy Inc., a developer of lead-cooled nuclear microreactors. Nuclea shareholders will receive exchangeable shares, resulting in approximately 96% ownership of the combined company, with existing Mango shareholders holding just 4%.

  • $15 Million PIPE Financing Condition

    Closing is contingent on a private investment in public equity (PIPE) of at least $15 million, to be funded into escrow and released at closing. Proceeds will cover $1.5 million in Mango liabilities, $1.5 million CEO severance, and provide working capital for Nuclea.

  • CEO Exit Package

    CEO Jacob Cohen will receive $1.5 million cash severance, 2 million fully vested shares (issued immediately), and a $10 million cashless warrant for Mango & Peaches Corp. stock upon deal completion. He will transition to President as a consultant.

  • Governance Changes to Secure Approval

    The board amended bylaws to reduce the shareholder meeting quorum from a majority to one-third of voting power, making it easier to achieve the required stockholder vote. The company also issued 400,000 fully vested shares to directors and the CFO.


Analysis · MGRX · Industrial Applications And Services

A struggling men's wellness company with a going concern warning and a sub-$10 million market cap, Mangoceuticals is being acquired in a reverse merger by Nuclea Energy, a private Canadian nuclear microreactor developer. Existing Mango shareholders will be diluted to approximately 4% ownership, while Nuclea shareholders will control 96% post-closing. The deal is contingent on a minimum $15 million PIPE financing — a lifeline for the cash-strapped company — and requires Nasdaq and shareholder approvals. CEO Jacob Cohen is exiting with a $1.5 million cash severance, 2 million shares, and a $10 million warrant. The board also lowered the shareholder meeting quorum to one-third, easing the path to approval. This is a complete transformation of the company's business and capital structure.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MGRX was trading at $0.54 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $9.5M. The 52-week trading range was $0.16 to $2.75. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MGRX - Latest Insights

MGRX
Nov 16, 2026, 5:25 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.1615
Real-time Price: $0.124 info
Change: -$0.0375 (-23%) info
Market Cap: $2.747M info
MGRX
Nov 13, 2026, 5:25 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.155
Real-time Price: $0.124 info
Change: -$0.031 (-20%) info
Market Cap: $2.747M info
MGRX
Nov 12, 2026, 7:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.2078
Real-time Price: $0.124 info
Change: -$0.0838 (-40%) info
Market Cap: $2.747M info
MGRX
Nov 06, 2026, 5:25 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.190
Real-time Price: $0.124 info
Change: -$0.066 (-35%) info
Market Cap: $2.747M info
MGRX
Nov 06, 2026, 5:25 PM EST
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.190
Real-time Price: $0.124 info
Change: -$0.066 (-35%) info
Market Cap: $2.747M info